These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35154241)

  • 21. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 22. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma.
    Deng Y; Zhang F; Sun ZG; Wang S
    Front Med (Lausanne); 2021; 8():762570. PubMed ID: 34970559
    [No Abstract]   [Full Text] [Related]  

  • 24. Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
    Song ZB; Yu Y; Zhang GP; Li SQ
    Front Cell Dev Biol; 2021; 9():728574. PubMed ID: 34676211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
    Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C
    Front Genet; 2021; 12():758596. PubMed ID: 35069679
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression levels of lncRNAs are prognostic for hepatocellular carcinoma overall survival.
    Xue C; Zhao Y; Jiang J; Li L
    Am J Transl Res; 2020; 12(5):1873-1883. PubMed ID: 32509183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.
    Chen S; Li X; Zhang J; Li L; Wang X; Zhu Y; Guo L; Wang J
    J Gastrointest Oncol; 2021 Oct; 12(5):2157-2171. PubMed ID: 34790382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
    Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
    [No Abstract]   [Full Text] [Related]  

  • 31. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
    Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
    J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma.
    Wu Y; Wang PS; Wang BG; Xu L; Fang WX; Che XF; Qu XJ; Liu YP; Li Z
    Cancer Med; 2018 Dec; 7(12):6219-6233. PubMed ID: 30378276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
    Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
    World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma.
    Zhou C; Zhang H; Lu L
    Front Genet; 2021; 12():744113. PubMed ID: 34650600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
    Deng X; Bi Q; Chen S; Chen X; Li S; Zhong Z; Guo W; Li X; Deng Y; Yang Y
    Front Mol Biosci; 2020; 7():611626. PubMed ID: 33505990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
    Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
    Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.